Indonesia Looks to India on Pharma Growth

Indonesia's president praised India's pharmaceutical and medical technology advances at the 23rd ASEAN-India Summit in Manila.

Updated on Nov. 17, 2026 in Healthcare

Photograph of a sterile pharmaceutical production hall with stainless-steel vessels and a glass flask of amber liquid on a steel bench in the foreground.
Indonesian President Prabowo Subianto praised India's pharmaceutical and medical technology advances at the 23rd ASEAN-India Summit in Manila, Philippines. AI Illustration. Upload story photo >

Live Poll

Should Indonesia rely more on India for affordable medicines?

Prabowo Subianto, President of Indonesia, praised advancements in India's pharmaceutical and medical technology sectors during his remarks at the 23rd ASEAN-India Summit in Manila, Philippines. Indonesia reaffirmed its intention to learn from India in building national health resilience and strengthening its domestic pharmaceutical industry.

Why it matters

Indonesia has existing cooperative programs with India to supply medicines, pharmaceutical products, and medical equipment at affordable costs, and the remarks signal a continued push to strengthen those ties. For the wider Southeast Asia region, closer cooperation on medicine supply and health resilience could influence how member states approach domestic drug production.

The remarks were made at the 23rd ASEAN-India Summit, part of the 49th ASEAN Summit series. No financial figures, supply volumes, or deal values for the Indonesia-India pharmaceutical cooperation were disclosed in the available material.

The players

Prabowo Subianto

Prabowo Subianto is President of Indonesia and a former defense minister who has pursued closer regional defense and economic ties.

The details

Prabowo made the remarks during his intervention at the summit, praising India's progress in pharmaceuticals and medical technology. He also called for stronger cooperation with India on disaster risks, and Indonesia said it wants to draw on India's experience in building national health resilience.

Timeline

  1. November 17, 2026: Prabowo delivers remarks at the 23rd ASEAN-India Summit in Manila.

Industry Context

The 23rd ASEAN-India Summit, held in Manila, is the latest edition of a recurring leaders' forum linking the Association of Southeast Asian Nations with India. Remarks on pharmaceutical and health cooperation extend that forum's agenda beyond trade and disaster preparedness into medicine supply.

For patients in the region, closer Indonesia-India cooperation could eventually affect the availability and cost of generic medicines and medical equipment, though the source gives no timeline for these changes. The remarks describe intent and existing programs rather than new price or availability changes that readers can act on now.

The takeaway

Regional health supply is increasingly a matter of cross-border cooperation, and Indonesia's stated interest in India's pharmaceutical model signals that domestic drug production is becoming a policy priority across Southeast Asia.

Further reading

For more on how governments are shaping drug supply, see our Healthcare coverage.

Live Poll

Should Indonesia rely more on India for affordable medicines?